Ten-Gene Biomarker Panel: a New Hope for Ovarian Cancer?

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

DJ Cheon is supported by an Ovarian Cancer Research Fund Ann Schreiber Mentored Investigator Award and the University of California Office of the President’s Tobacco-Related Disease Research Program (293017). S Orsulic is supported by grants from the American Cancer Society (RSG-10-252-01-TBG), Sandy Rollman Ovarian Cancer Foundation, Margaret E Early Medical Research Trust, Pacific Ovarian Cancer Research Consortium (Developmental Grant, P50 CA083636) and the National Center for Advancing Translational Sciences (UL1TR000124), as well as funds from the Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. DJ Cheon and S Orsulic are the original inventors of the pending patent (PCT/US2013/065537). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Additional information

Funding

DJ Cheon is supported by an Ovarian Cancer Research Fund Ann Schreiber Mentored Investigator Award and the University of California Office of the President’s Tobacco-Related Disease Research Program (293017). S Orsulic is supported by grants from the American Cancer Society (RSG-10-252-01-TBG), Sandy Rollman Ovarian Cancer Foundation, Margaret E Early Medical Research Trust, Pacific Ovarian Cancer Research Consortium (Developmental Grant, P50 CA083636) and the National Center for Advancing Translational Sciences (UL1TR000124), as well as funds from the Women’s Cancer Program at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center. DJ Cheon and S Orsulic are the original inventors of the pending patent (PCT/US2013/065537). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.